Cargando…
Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein
Cardiovascular disease is the leading worldwide cause of death. Apolipoprotein E (ApoE) is a 34-kDa circulating glycoprotein, secreted by the liver and macrophages with pleiotropic antiatherogenic functions and hence a candidate to treat hypercholesterolaemia and atherosclerosis. Here, we describe a...
Autores principales: | Papaioannou, Ioannis, Simons, J. Paul, Owen, James S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356902/ https://www.ncbi.nlm.nih.gov/pubmed/22645694 http://dx.doi.org/10.1155/2012/148796 |
Ejemplares similares
-
Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100
por: Tse, Kevin, et al.
Publicado: (2013) -
LXRα is uniquely required for maximal reverse cholesterol transport
and atheroprotection in ApoE-deficient mice
por: Hong, Cynthia, et al.
Publicado: (2012) -
Dose-Dependent Induction of an Idiotypic Cascade by Anti-Glycosaminoglycan Monoclonal Antibody in apoE(−/−) Mice: Association with Atheroprotection
por: Sarduy, Roger, et al.
Publicado: (2017) -
Fusobacterium nucleatum Alters Atherosclerosis Risk Factors and Enhances Inflammatory Markers with an Atheroprotective Immune Response in ApoE(null) Mice
por: Velsko, Irina M., et al.
Publicado: (2015) -
Anti‐Inflammatory Immune Skewing Is Atheroprotective: Apoe(−/−)FcγRIIb(−/−) Mice Develop Fibrous Carotid Plaques
por: Harmon, Erin Y., et al.
Publicado: (2014)